Literature DB >> 11641233

Cyclooxygenase-independent actions of cyclooxygenase inhibitors.

I Tegeder1, J Pfeilschifter, G Geisslinger.   

Abstract

Several studies have demonstrated unequivocally that certain nonsteroidal anti-inflammatory drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti-inflammatory and antiproliferative effects independent of cyclooxygenase activity and prostaglandin synthesis inhibition. These effects are mediated through inhibition of certain transcription factors such as NF-kappaB and AP-1. The respective NSAIDs might interfere directly with the transcription factors, but their effects are probably mediated predominantly through alterations of the activity of cellular kinases such as IKKbeta, Erk, p38 MAPK, or Cdks. These effects apparently are not shared by all NSAIDs, since indomethacin failed to inhibit NF-kappaB and AP-1 activation as well as Erk and Cdk activity. In contrast, indomethacin was able to activate PPARgamma, which was not affected by sodium salicylate or aspirin. The differences in cyclooxygenase-independent mechanisms may have consequences for the specific use of these drugs in individual patients because additional effects may either enhance the efficacy or reduce the toxicity of the respective compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641233     DOI: 10.1096/fj.01-0390rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  166 in total

1.  Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors:  Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro.

Authors:  James K Liu; Smruti K Patel; David L Gillespie; Kum Whang; William T Couldwell
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

Review 3.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 4.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

5.  Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture.

Authors:  Wenjin Li; Shasha Wu; Robert W Hickey; Marie E Rose; Jun Chen; Steven H Graham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

6.  CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.

Authors:  B P Imbimbo; B Hutter-Paier; G Villetti; F Facchinetti; V Cenacchi; R Volta; A Lanzillotta; M Pizzi; M Windisch
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

7.  Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Authors:  Xiao-Min Wang; Tian-Xia Wu; May Hamza; Edward S Ramsay; Sharon M Wahl; Raymond A Dionne
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

8.  Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Kazuhide Higuchi; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Andrzej S Tarnawski; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 9.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

10.  Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression.

Authors:  N Yu; M-L Zhu; B Johnson; Y-P Liu; R O Jones; H-B Zhao
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.